Yasin Akbari

Royalty Monetization In An Era Of Drug Pricing Pressure: How The IRA Is Affecting Royalty Monetizations

Life Sciences Licensing And M&A Update: Catching Up On Recent Decisions Affecting Commercially Reasonable Efforts Definitions And Post-Patent Expiration Royalty Obligations